1-4 of 4
Tohru Izumi
Close
Sort by
Journal Articles

Favorable Outcomes of Newly Diagnosed Intravascular Large B-Cell Lymphoma Patients Treated with R-CHOP Combined with High-Dose Methotrexate Plus Intrathecal Chemotherapy: Results from a Multicenter Phase 2 Trial (PRIMEUR-IVL)

Kazuyuki Shimada, MD, Motoko Yamaguchi, MD PhD, Yoshiko Atsuta, MD PhD, Kosei Matsue, MD PhD, Keijiro Sato, MD, Shigeru Kusumoto, MD PhD, Hirokazu Nagai, MD PhD, Jun Takizawa, MD PhD, Noriko Fukuhara, MD PhD, Koji Nagafuji, MD PhD, Kana Miyazaki, MD PhD, Eiichi Ohtsuka, MD, Masataka Okamoto, MD PhD, Yasumasa Sugita, MD PhD, Toshiki Uchida, MD PhD, Satoshi Kayukawa, MD, Atsushi Wake, MD PhD, Daisuke Ennishi, MD PhD, Yukio Kondo, MD, Tohru Izumi, MD, Yoshihiro Kin, MD, Kunihiro Tsukasaki, MD PhD, Daigo Hashimoto, Masaaki Yuge, MD PhD, Atsumi Yanagisawa, Yachiyo Kuwatsuka, MD PhD, Satoko Shimada, MD, Yasufumi Masaki, MD PhD, Nozomi Niitsu, MD PhD, Hitoshi Kiyoi, MD PhD, Ritsuro Suzuki, MD PhD, Takashi Tokunaga, MD PhD, Shigeo Nakamura, MD, Tomohiro Kinoshita, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 350.
https://doi.org/10.1182/blood-2019-126798
Published: 2019
Journal Articles

Expression of CD56 Is an Independent Prognostic Factor to Predict Relapse in Acute Myeloid Leukemia with t(8;21): Results of Japan Adult Leukemia Study Group (JALSG) AML97 Protocol.

Noriyoshi Iriyama, Yoshihiro Hatta, MD, PhD, Jin Takeuchi, MD, PhD, Yoshiaki Ogawa, MD, PhD, Shigeki Ohtake, MD, PhD, Toru Sakura, MD, PhD, Kinuko Mitani, MD, Fumihiro Ishida, MD, Masatomo Takahashi, MD, Tomoya Maeda, MD, PhD, Tohru Izumi, MD, Hisashi Sakamaki, MD, Shuichi Miyawaki, MD, Sumihisa Honda, PhD, Yasushi Miyazaki, MD, PhD, Tomohiko Taki, MD, PhD, Masafumi Taniwaki, MD, PhD, Tomoki Naoe, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2511.
https://doi.org/10.1182/blood.V120.21.2511.2511
Published: 2012
Journal Articles

Role of Hematopoietic Stem Cell Transplantation As Salvage Treatment of Acute Promyelocytic Leukemia Initially Treated with All- Trans -Retinoic Acid: A Retrospective Analysis of the Japan Adult Leukemia Study Group (JALSG) APL97 Study

Hiroyuki Fujita, MD, PhD, Norio Asou, MD, PhD, Masako Iwanaga, MD, PhD, MPH, Rie Hyo, MD, Shosaku Nomura, MD, PhD, Hitoshi Kiyoi, MD, PhD, Masaya Okada, MD, PhD, Motohiro Tsuzuki, MD, Mitsuhiro Matsuda, MD, PhD, Takahiro Yamauchi, MD, PhD, Shigeki Ohtake, MD, PhD, Tohru Izumi, MD, Chiaki Nakaseko, MD, PhD, Kinuko Mitani, MD, Katsuji Shinagawa, Akihiro Takeshita, MD, PhD, Yasushi Miyazaki, MD, Kazunori Ohnishi, MD, PhD, Shuichi Miyawaki, MD, Tomoki Naoe, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2036.
https://doi.org/10.1182/blood.V118.21.2036.2036
Published: 2011
Journal Articles

Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma

Jiro Kikuchi, Taeko Wada, Rumi Shimizu, Tohru Izumi, Miyuki Akutsu, Kanae Mitsunaga, Kaoru Noborio-Hatano, Masaharu Nobuyoshi, Keiya Ozawa, Yasuhiko Kano, Yusuke Furukawa
Journal: Blood
Blood (2010) 116 (3): 406–417.
https://doi.org/10.1182/blood-2009-07-235663
Published: 2010
Includes: Supplemental data